Current Studies

Myomo is pioneering a new class of non-invasive neuromuscular therapy designed to facilitate muscle-re-education and improve the motor abilities of individuals who suffer from upper extremity hemiparesis due to neurological injuries. We are partnering with leading clinics and researchers with expertise in stroke as well as other neurological and physiological disorders to advance the efficacy of therapeutic interventions targeting upper extremity motor impairments.

This section is designed to provide information on current clinical studies using the Myomo e100 NeuroRobotic System.

Note: Federal (USA) law restricts this device to sale by or on the order of a physician or physical therapist.

Note: The Myomo e100 NeuroRobotic System is intended for clinical use by patients with their treating medical professional. The device has not been shown to be safe or effective as a functional aid for use in the home.